F1t3 receptor expression on the surface of malignant hematopoietic cells and responses to F1t3 ligand stimulation
- 39 Downloads
Abstract
Objective: To investigate the F1t3 receptor expression on the surface of malignant hematopoietic cells, the effect of TNFα and dexamethasone (DXM) on its expression and the responses of those cells to recombinant human F1t3 ligand (rhFL). Methods: Eighteen malignant hematopoietic cell lines were determined for the F1t3 receptor expression by flow cytometric analysis. The effect of rhFL on the proliferation of malignant hematopoietic cellsin vitro was measured using MTT assay. Results: The expressions of F1t3 receptor on the surface of Raji, Daudi, HL-60, 8266 and XG-6 cells were detected by flow cytometric analysis. Following incubation with 20 ng/ml TNFα for 24h, the number of F1t3 receptor positive cells decreased in Raji and 8266, increased in HL-60 and XG-6, and no difference in Daudi cells. After incubation with 10−6 mol/L DXM for 24h, the number of F1t3 receptor positive cells decreased in all the 5 F1t3 receptor positive cell lines. rhFL stimulated the proliferation of HL-60 and Raji cells. Conclusion: For most of the malignant hematopoietic cells, there was neither the expression of F1t3 receptor nor the response to rhFL. DXM may be useful to reduce the effect of FL on the proliferation of some F1t3 receptor positive malignant hematopoietic cells in vitro andin vivo.
Key words
F1t3 receptor Recombinant human F1t3 ligand (rhFL) Malignant hematopoietic cell lines Proliferation Dexamethasone (DXM)Preview
Unable to display preview. Download preview PDF.
References
- [1]Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61:203.PubMedCrossRefGoogle Scholar
- [2]Lyman SD, James L, Johnson L, et al. Cloning of the human homologue of the murine F1t3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795.PubMedGoogle Scholar
- [3]Sakabe H, Kimura T, Zeng ZZ, et al. Haematopoietic action of F1t3 ligand on cord blood-derived CD34-positive cells expressing different levels of F1t3 or c-kit tyrosine kinase receptor: comparison with stem cell factor. Eur J Haematol 1998; 60: 297.PubMedGoogle Scholar
- [4]Lynch DH, Andreason A, Maraskovsky E, et al. F1t3 ligand induces tumor regression and anti-tumor immune responsesin vivo. Nat Med 1997; 3: 625.PubMedCrossRefGoogle Scholar
- [5]Maraskovsky E, Daro E, Roux E, et al.In vivo generation of human dendritic cell subsets by F1t3 ligand. Blood 2000; 96: 878.PubMedGoogle Scholar
- [6]Xu ZX, Zhu JK, Zhang XG, et al. Expression of human F1t3 ligand inpichia pastoris and its biological characteristics. Acta Biochimica et Biophysica Sinica 2000; 32: 217.PubMedGoogle Scholar
- [7]Carmichel J, DeGraff WG, Gazdar AF, et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 1987; 47: 936.Google Scholar
- [8]Jacobsen SEW, Okkenhaug C, Myklebust J, et al. The F1t3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 1995; 181: 1357.PubMedCrossRefGoogle Scholar
- [9]Drexler HG. Expression of F1t3 receptor and response to F1t3 ligand by leukemic cells. Leukemia 1996; 10: 588.PubMedGoogle Scholar
- [10]Siitonen T, Savolainen ER, Koistinen P. F1t3 ligand does not induce the growth of peripheral blood granulocyte-macrophage colony-forming cells in myeloproliferative disorders. Eur J Haematol 1999; 62: 103.PubMedCrossRefGoogle Scholar
- [11]Drexler HG, Meyer C, Quentmeier H. Effects of F1t3 ligand on proliferation and survival of myeloid leukemia cells. Leuk Lymphoma 1999; 33: 83.PubMedGoogle Scholar
- [12]Meyer C, Drexler HG. F1t3 ligand inhibits apoptosis and promotes survival of myeloid leukemia cell lines. Leuk Lymphoma 1999; 32: 577.PubMedGoogle Scholar